The clinical studies have demonstrated the synergistic effects of GIP and GLP-1 agonism on glucose metabolism and body weight in these unimolecular dual agonists (63, 76), marking a significant achievement in the pharmaceutical development of incretins, which will be further discussed in the next section
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea
Ozdemirler Erata G, Kanbali O, Durlanik O, et al
CJC-1295 peptide therapy in Mumbai is offered with medical supervision and clear consent
It is made from several amino acids
Both of these peptides stimulate growth hormone release, both can lower body fat, body weight, and increase muscle mass